Home   »  TRADE TOPICS  »  Prescription Drugs  »  Public Leadership

Letter from ME Governor Baldacci to DHHS Secretary Kathleen Sebelius

Kathleen Sebelius, Secretary

Deparlment of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201

Dear Secretary Sebelius:

I am writing because I am concerned that the Administration is developing a trade policy that might ultimately constrain the ability of the State of Maine and the federal government to continue best practices to control pharmaceutical prices. This policy may be part of the "Special 301" report to be issued by the United States Trade Representative (USTR) by the end of this month. The USTR is not a health-regulatory authority and it has no expertise in public health matters. I hope that the USTR will reverse the previous administration's support for using trade policy to restrict governmental powers to control medicine prices, and I write to ask you to support this request and help develop a coherent administration policy that is consistent with the authority of the state and federal governments to continue pharmaceutical price-restraining policies...


Search
Unless otherwise expressly stated, all original material of whatever nature created by the Forum on Democracy & Trade website is licensed under a Creative Commons License. Privacy Statement | Sitemap